Astymin-C

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Astymin-C

Quick Facts

Property Description
Active Ingredients Ten Essential Amino Acids + Ascorbic Acid (Vitamin C)
Form Oral solution, Syrup, or Capsule
Pharmacological Class Nutritional Supplement (Amino Acid and Vitamin Formulation)
General Purpose Metabolic and structural support during deficiency or increased demand
Origin Synthetic/Pharmaceutical Grade

What Type of Preparation is Astymin-C? (Identity and Classification)

Astymin-C is a proprietary poly-component formulation classified as a Nutritional Supplement, specifically an Amino Acid and Vitamin Formulation, intended for oral administration. The preparation is widely recognized as an established brand in the nutritional support category, often available as an Oral solution or Syrup. Official pharmacological indexing places such preparations within the general category of vitamins and mineral supplements.

Composition: Essential Amino Acids and Vitamin C (Ingredients and Origin)

The active core of Astymin-C consists of ten specific L-form amino acids and the water-soluble vitamin, Ascorbic Acid (Vitamin C). The formula includes the essential branched-chain amino acids, such as L-leucine, L-isoleucine, and L-valine, alongside other essential and semi-essential components. These ingredients are produced to a Synthetic/Pharmaceutical Grade standard. The importance of these essential amino acids is clinically recognized because the human body cannot synthesize them sufficiently and must rely on external sources.

What is the General Purpose of Astymin-C? (High-Level Benefit)

The general purpose of Astymin-C is to provide immediate metabolic support and promote physiological integrity by supplying readily available precursors for protein synthesis. This blend of ingredients is typically used as an adjunctive therapy to support recovery following illness or trauma (convalescence) or when a state of nutritional deficiency state leads to general debility. The antioxidant activity of Vitamin C is acknowledged to support cellular integrity, reinforcing the overall nutritional benefit during times of increased physical demand.

Regulatory References

  1. Amino acids: MedlinePlus Medical Encyclopedia
  2. Multivitamin/mineral Supplements - Health Professional (NIH ODS)

What side effects are possible with Astymin-C?

Adverse Effects and Safety Information

The safety profile for Astymin-C, a nutritional supplement containing Vitamin C and amino acids including L-Lysine, is primarily related to the potential for common gastrointestinal discomfort.

Adverse Reaction Scope

Classification System-Organ Class Involved Adverse Reactions
Common (based on components) Gastrointestinal System Nausea, vomiting, stomach pain, heartburn, diarrhea, and stomach cramps.
Less Common/Other Skin and Subcutaneous Tissue Hypersensitivity or allergic reactions (e.g., skin rash).
Less Common/Other Nervous System Headache, lightheadedness, or drowsiness.

Side effects are generally considered rare when the product is used as intended. However, exceeding recommended doses, particularly for the Vitamin C component, may increase the likelihood of experiencing these effects.

Safety-Related Restrictions and Considerations

Contraindications: The use of Astymin-C is contraindicated in individuals with known hypersensitivity or allergy to any of its active components or excipients. Formal regulatory documentation has also listed conditions such as eosinophilia-myalgia syndrome as a contraindication.

Population-Specific Precautions: Caution is advised in patients with pre-existing conditions affecting the liver or kidneys. Regulatory notes state that the product is not indicated for use in pregnant or breastfeeding women. The product is also noted to potentially cause drowsiness, requiring caution when performing activities that demand mental alertness.

Safety Monitoring: Discontinuation of use and immediate medical consultation are required if any unusual or allergic symptoms are observed. This monitoring approach is consistent with the safety management of multi-component supplements where individual ingredient risks are managed via general post-market surveillance and reporting.

Overdose and Emergency Response

Overdose and when to seek help

The documented profile for overdosage of this nutritional supplement is primarily driven by the established toxicity of the high-dose Ascorbic Acid (Vitamin C) component. Acute over-ingestion is formally defined by gastrointestinal distress, commonly presenting as diarrhoea, nausea, vomiting, and stomach cramps.

Massive overdosage is associated with potentially life-threatening outcomes. Regulatory documents list the potential for acute renal failure due to the formation of renal oxalate calculi, a severe metabolic complication. Furthermore, acidosis may be a finding. A critical, population-specific risk is the development of severe haemolytic anaemia in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency following massive ingestion. Patients with a history of kidney stones or existing renal disease also face an officially increased risk of oxalate nephropathy.

Immediate medical attention must be sought if any severe symptoms, such as persistent vomiting or signs of compromised renal function, manifest. The official management approach is symptomatic and supportive treatment, and no specific antidote is known. Regulatory guidance mandates the monitoring of renal function and blood counts in cases of suspected overdose to detect these severe complications.

Therapeutic Uses of Astymin-C

What Astymin-C Treats: Main Uses and Benefits

The therapeutic role of the key components involves the utilization of essential amino acids and Vitamin C.


Managing General Debility and Nutritional Deficiency Symptoms

This preparation is primarily used to address symptom clusters of generalized weakness, pervasive fatigue, and lethargy that stem from a documented or suspected nutritional deficiency. Vitamin C supports functions relevant to energy, and its insufficiency is commonly linked to symptoms of fatigue. Supplementation provides metabolic support that contributes to easing the physiological strain and supports general well-being during periods of depletion.


Supporting Convalescence and Tissue Recovery

Astymin-C is commonly applied in addressing situations of convalescence, the recovery phase following acute illness, trauma, or surgery. By supplying nutritional components, it may assist with managing symptoms related to compromised structural integrity and supports the patient during the recovery phase, which contributes to easing the physical debility associated with a prolonged recovery period.

“This supportive nutritional input helps maintain a sense of stability when symptoms are more noticeable.”

The Vitamin C component supports tissue integrity and wound healing, addressing the symptoms related to compromised structural support. The primary therapeutic uses include the supportive management of nutritional deficiency states, convalescence following illness, and conditions associated with symptoms of poor structural recovery.


Reinforcing Resistance and Growth in Vulnerable Groups

The formulation is commonly used to help with supporting the body's defense mechanisms, often during periods of stress or when vulnerability to recurrent infections is heightened. Furthermore, it is relevant for easing developmental concerns, offering the fundamental building blocks necessary for proper growth and development in children where dietary intake may be suboptimal.



Quick Fact: Relief for Fatigue and Weakness Astymin-C is commonly used to help with the symptoms of general debility and lethargy that arise from inadequate nutritional supply, providing supplementary support during times of high metabolic need.


Eligibility and Restrictions for Use

Who can and cannot use Astymin-C

Official regulatory information defines the eligibility for Astymin-C (Oral solution/Syrup/Capsule) based on contraindications, age, and existing health conditions.


Populations Permitted to Use Astymin-C

Use is established and permitted for all age groups requiring nutritional support:

  • Pediatric Population: Use is permitted for children and infants, including during growth periods.
  • Adult and Older Adult Populations: Use is permitted, with no specific precautions required for the elderly population.
  • Pregnancy and Lactation: The product is generally considered safe for use during both pregnancy and breastfeeding for nutritional supplementation.

Absolute Contraindications

Category Eligibility Rule
Hypersensitivity Individuals with a known allergy or hypersensitivity to any of the ingredients in the formulation (amino acids, Vitamin C, etc.) must not use the medicine.

Population-Based Restrictions

Conditional use is required in specific patient groups:

  • Renal Impairment: Use requires caution in patients with kidney disease (renal impairment).
  • Metabolic Restrictions: Caution is advised for patients on specialized restricted lysine or leucine diets due to the supplement's amino acid content.

What should I know about interactions with other medicines?

Astymin-C Interactions with other medicines and products — Official Regulatory Information

Astymin-C is a multi-component preparation containing amino acids and high-dose Ascorbic Acid (Vitamin C), primarily classified as a dietary supplement or a combination medicine in various regulatory regions. Interaction information is primarily derived from the known effects of the key component, Ascorbic Acid.

Interaction Scope Details as stated in official labeling
Medicinal product categories with documented interactions Iron-chelating agents, specific Anticoagulants, Aluminum-containing Antacids, certain Chemotherapy and Antiretroviral agents.
Specific interacting medicines (if explicitly listed) Deferoxamine, Warfarin, Indinavir.
Mechanistic basis of interactions (only if stated in label) Altered absorption of co-administered substances due to changes in gastrointestinal acidity; Altered systemic drug levels due to effects on drug metabolism; Mobilization of tissue iron stores.
Timing-based interaction rules (if applicable) Ascorbic acid should not be initiated until at least one month after starting therapy with iron-chelating agents such as Deferoxamine.
Population-specific interaction notes (if applicable) Caution is noted in patients with cardiac dysfunction or pre-existing iron overload when combined with iron-chelating agents. Acute hemolysis has been reported in patients with Glucose-6-phosphate Dehydrogenase (G6PD) deficiency following high-dose Ascorbic Acid.
Interaction-related restrictions High doses of Ascorbic Acid may decrease the effects of Anticoagulants (like Warfarin) and certain antiviral agents (like Indinavir). Co-administration with Aluminum-containing Antacids may increase aluminum absorption.

Official interaction statements:

  • • The co-administration of high-dose Ascorbic Acid with the iron-chelator Deferoxamine is associated with an increased risk of cardiac dysfunction due to enhanced iron mobilization.
  • • Ascorbic Acid may reduce the effectiveness of blood-thinning agents, necessitating monitoring of blood clotting parameters.
  • • Certain drug assays and diagnostic tests, particularly those for glucose and creatinine, may be falsely altered by the presence of high concentrations of Ascorbic Acid in the urine or blood.

Connection to the overall interaction profile: Regulatory documents define the interaction profile of this multi-component product based on the known pharmacological and chemical properties of Ascorbic Acid. The documented constraints center on modifying the levels of other co-administered drugs and managing the risk of enhanced iron toxicity in specific clinical settings, requiring management modifications relative to these known effects.

Mechanism of Action

Direct Anabolic Substrate Provision and Signaling

The mechanism involves supplying essential amino acids as critical building blocks for the ribosomal machinery, initiating the process of protein synthesis and supporting the formation of structural and functional polypeptides. Specific amino acids, such as L-Leucine, also act as signaling molecules to activate key growth pathways (e.g., mTOR), modulating anabolism and contributing to the establishment of a positive nitrogen balance.


Cofactor Function and Structural Integrity Support

The mechanism of Ascorbic Acid (Vitamin C) is based on its role as an essential reductant that maintains the activity of hydroxylase enzymes. This cofactor function is non-negotiable for the post-translational modification of proline and lysine residues, which is the crucial step that stabilizes the collagen triple helix structure. This action ensures the required structural stability and cross-linking of connective tissue proteins.


Synergistic Action and Cellular Protection

The formulation's components exhibit synergy where the amino acids provide the raw polypeptide material, and the Ascorbic Acid provides the chemical assistance required to finalize and stabilize the structure. Additionally, Ascorbic Acid functions as a potent, water-soluble antioxidant, actively scavenging Reactive Oxygen Species (ROS); this activity results in the reduced oxidation of cellular machinery and proteins during metabolic stress.

Dosage and Administration Information

How to Use Astymin-C

The official instructions for using Astymin-C define the precise methods, timing, and dosage volumes established for this nutritional supplement. The preparation, which contains essential amino acids and Vitamin C, is typically administered through the oral route as a solution, syrup, or drops.


Administration Scope

Feature Guideline
Route of administration: The primary prescribed route is Oral. The complex amino acid core is also used for Intravenous Infusion in related formulations, demonstrating a high-level usage principle.
Dosing schedule: Administration follows a fixed-volume regimen (e.g., milliliters or drops). Official schedules are typically defined by age group, not by patient weight or titrated clinical response.
Timing in relation to meals: Administration is generally instructed to occur with food or immediately following a meal.
Age-group administration rules: Explicit age-based dosing must be followed, with distinct prescribed volumes for infants, children, and adults.
Special procedural conditions: The use of a calibrated oral measuring device (dropper or cup) is a mandatory procedural step to ensure the precise delivery of the volume prescribed.

Resulting Procedural Structure

The administration protocol requires the measured volume of the solution to be accurately drawn using the calibrated device. This dose is then delivered once daily or twice daily, often in conjunction with a meal. The intended duration of use is continuous, spanning the period of sustained nutritional demand or recovery. Proper usage dictates strict adherence to the age-specific volume and the procedural constraint of not exceeding the daily recommended dosage volume, as defined in the official prescribing information.

Recent Clinical Evidence

Astymin-C: Recent Clinical Evidence

Astymin-C is a nutritional supplement formulated to provide a combination of essential amino acids and Vitamin C (Ascorbic Acid), often along with other vitamins like Thiamine Nitrate (Vitamin B1) and Tocopherol (Vitamin E), depending on the specific product variant (e.g., drops, liquid, or injection).


Role of Key Components

While studies focusing specifically on the Astymin-C formulation as a single entity are limited, clinical evidence supports the therapeutic roles of its individual active components in addressing various nutritional and physiological processes:

  • Essential Amino Acids (e.g., L-Lysine, L-Leucine): These are the fundamental building blocks for protein synthesis, which is vital for tissue repair, muscle development, and the production of hormones and enzymes. For example, L-Lysine is studied for its role in calcium absorption and collagen formation, while branched-chain amino acids like L-Leucine and L-Isoleucine are involved in energy metabolism and muscle healing.
  • Vitamin C (Ascorbic Acid): As a potent antioxidant, Vitamin C is crucial for protecting cells from oxidative stress. It is necessary for the biosynthesis of collagen, supporting connective tissue and wound healing. Furthermore, it plays a key role in immune function and enhances the absorption of non-heme iron.

Indications and Safety Profile

Formulations containing these components are clinically used to manage nutritional deficiencies and support the body during periods of convalescence (recovery from illness or surgery), general debility, and conditions associated with increased metabolic demand. The amino acids and vitamins contribute to a balanced nutritional profile, aiming to support growth and immune health, particularly in pediatric and recovering populations.

Astymin-C and similar amino acid-vitamin supplements are generally well-tolerated when taken at prescribed dosages. Potential side effects are usually mild and may include gastrointestinal upset such as nausea or stomach discomfort. Caution is advised for individuals with pre-existing kidney or liver conditions, as amino acid supplementation may require dose adjustment.

Frequently Asked Questions (FAQ)

Common questions about Astymin-C (FAQ)


Q: Is Astymin-C different from regular Vitamin C tablets?

A: Yes, Astymin-C is a poly-component nutritional supplement, meaning it contains more than one active ingredient. Official information confirms it contains both Ascorbic Acid (Vitamin C) and a combination of Essential Amino Acids. Regular Vitamin C tablets, in contrast, typically contain only Ascorbic Acid.


Q: Do Astymin-C and iron supplements interact with each other?

A: Studies and official information indicate that the Ascorbic Acid (Vitamin C) in the product can enhance the absorption of non-heme iron. This is a known interaction based on the component's properties and is a common factor when using combination supplements.


Q: Are there any known allergic reactions to Astymin-C?

A: Official safety information states that hypersensitivity or allergic reactions (such as a skin rash) are reported as a less common side effect. Regulatory documents also state that the product is contraindicated (should not be used) if a person has a known allergy to any of its specific ingredients.


Q: Does Astymin-C contain sugar or artificial sweeteners?

A: The active ingredients listed are amino acids and Vitamin C. However, the oral solution or syrup forms typically contain inactive ingredients such as sweeteners, flavors, or preservatives. The complete list of ingredients is available on the specific product’s approved label.


Q: Are there any warnings about driving or operating machinery while taking Astymin-C?

A: Yes, official regulatory notes mention that the product can potentially cause drowsiness or affect mental alertness. Regulatory notes state that this potential for drowsiness requires caution when performing activities that demand mental alertness, such as driving or operating machinery.


Q: Is it okay to take Astymin-C if I have a chronic condition?

A: Official information advises caution for patients with pre-existing conditions affecting the liver or kidneys. For any chronic condition, it is typically recommended to confirm the appropriateness of the supplement with a healthcare provider.


Q: Can Astymin-C be crushed or split?

A: The administration protocol for solution forms requires the use of a calibrated measuring device to ensure precision. For solid forms (capsules), official labeling usually specifies taking them whole unless a specific instruction to crush or split is provided.


Q: What's the maximum duration Astymin-C is usually recommended for?

A: The product's usage protocol describes the intended duration as continuous, covering the period of sustained nutritional demand or recovery. Extended or long-term use is typically managed with professional oversight.


Q: Why is Astymin-C available in different forms (e.g., capsules, syrup)?

A: The product is manufactured in different forms, such as oral solution, syrup, and capsule, to accommodate various needs. This allows for easier administration to different age groups (e.g., syrup for children or infants) and provides options based on patient preference.


Q: Is Astymin-C suitable for vegetarians or vegans?

A: The active ingredients—the amino acids and Vitamin C—are generally produced to a synthetic, pharmaceutical grade. However, the suitability for vegetarian or vegan diets depends on the source of the specific excipients (inactive ingredients) used in the final product’s coating or liquid base. The full ingredient list on the product label will confirm the status of these inactive ingredients.


Q: What should I look for on the label to ensure I have the real Astymin-C product?

A: Official regulatory guidelines require the label to display specific information to verify the product. You should look for the official product name, the specific list of active ingredients, the manufacturer's information, and the required batch/lot number.


Q: Are headaches a potential side effect of Astymin-C?

A: According to the official product information, headache is listed as one of the less common adverse reactions that a person may experience while taking the product.


Q: Can Astymin-C be taken during flu or cold season?

A: Regulatory information indicates the product’s general purpose is to provide metabolic support and assist with recovery during periods of convalescence (getting better after an illness). The component Vitamin C is also acknowledged for its role in supporting immune function.


Q: Are there any specific patient groups who should avoid Astymin-C?

A: Yes, official information identifies specific groups. The product is absolutely contraindicated for anyone with a known allergy to its components. Additionally, caution is advised for patients with renal impairment or those following certain restricted diets (e.g., restricted lysine or leucine) due to the amino acid content.


Q: Is the absorption of Astymin-C affected by food?

A: The official administration instructions recommend taking the product with food or immediately after a meal. This timing is typically advised to help with the overall absorption of the nutrients and to minimize potential gastrointestinal discomfort.


Q: Does taking Astymin-C affect laboratory test results?

A: Yes, the presence of high concentrations of Ascorbic Acid (Vitamin C) can sometimes interfere with certain lab tests. Regulatory documents warn that this can falsely alter diagnostic test results, particularly those checking for glucose and creatinine levels.


Q: Are there any interactions between Astymin-C and alcohol?

A: While there may be no explicit regulatory statement about a specific chemical interaction with alcohol, official safety notes indicate the product can cause drowsiness. The potential for compounded drowsiness is a consideration when combining the product with alcohol.


Q: Does Astymin-C affect sleep patterns?

A: Official safety documents include drowsiness as a less common adverse reaction. Since drowsiness is a central nervous system effect, it could potentially be related to changes in a person's normal sleep patterns.

How should Astymin-C be stored and disposed of?

Storage Requirements

The official labeling for Astymin-C mandates specific environmental conditions to maintain the stability and quality of the oral solution. The product must be kept in a cool place, often specified as storage below 25 C for similar formulations, and must be protected from both direct sunlight and light in general. It is required to store the medicine in a dark and dry place, away from moisture. To prevent accidental ingestion, the product must be kept out of reach of children, as specified in regulatory documents.

Disposal Instructions

Once the product has been used or has expired, any unused remainder of the medicine must be discarded and not stored for later use. Disposal of Astymin-C should follow local governmental guidelines or regulatory body instructions for pharmaceutical waste. The official labeling does not include instructions for disposal into wastewater or household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Astymin-C found in:

A-Z Index: